Author Information
Kenneth W. Kinzler is affiliated with the Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins University School of Medicine, located in Baltimore, MD, USA. His work is highly influential in the field of cancer genetics and therapeutics, making significant strides in understanding and treating cancer.
Research Contributions
Kenneth W. Kinzler has made substantial contributions to the fields of cancer genetics, therapeutics, and immunotherapy. His recent publications cover a wide range of topics, including the use of bispecific antibodies to target the HIV-1 reservoir, non-invasive urine assays for cancer detection, and the development of mutational signatures related to obesity and other factors in cancer. Notably, his work on alpha-1 adrenergic receptor antagonists and their potential in preventing hyperinflammation and death from lower respiratory tract infections, including COVID-19, has garnered attention. Additionally, his research on neoantigens and chimeric antigen receptors is pioneering in cancer immunotherapy.
Aliases
Kenneth W. Kinzler is known by several aliases, including K Enneth W. Kinzler, Kenneth W Kinzler, Kenneth W. Kinzler, K Kinzler, Kenneth Kinzler, Ken Kinzler, K W Kinzler, K. W. Kinzler, K.w. Kinzler, and Ken W Kinzler. Publication and Citation Metrics
| Metric |
Value |
| Total Papers |
622 |
| Total Citations |
246,995 |
| H-index |
220 |
